Knowledge Graph · Medication
Selective Estrogen Receptor Modulators
Drug class acting as estrogen agonist or antagonist depending on tissue.
Authoritative sources
Evidence base
Meta-Analysis · 2025
Advances in nutrition (Bethesda, Md.) · Viscardi G, Back S, Ahmed A, Yang S, et al.
Systematic Review · 2025
Hormonal treatment of aggressive angiomyxoma
Current problems in cancer · Maciejczyk A, Bartecki K, Czarnecka AM, Szumera-Ciećkiewicz A, et al.
Journal Article · 2025
Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials
Breast cancer research : BCR · Pourali G, Liu M, Sherpa SS, Hardi A, et al.
Systematic Review · 2025
European journal of endocrinology · Santi D, Pallotti F, Tienforti D, Spaggiari G, et al.
Systematic Review · 2023
Calcified tissue international · Moshi MR, Nicolopoulos K, Stringer D, Ma N, et al.
Meta-Analysis · 2023
Andrology · Tienforti D, Castellini C, Di Giulio F, Totaro M, et al.
Systematic Review · 2023
Archives of osteoporosis · Nicolopoulos K, Moshi MR, Stringer D, Ma N, et al.
Randomized Controlled Trial · 2021
Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice
Human reproduction update · Genazzani AR, Monteleone P, Giannini A, Simoncini T
Where Selective Estrogen Receptor Modulators appears on Kindr Health
Data hub
This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.